Valinomycin
SIGMA/94675 - ≥99.0% (TLC)
Synonym: Cyclo(L-Val-D-HyIva-D-Val-L-Lac-)3: HyIva = α-Hydroxyisovaleric acid, Lac = Lactic acid
CAS Number: 2001-95-8
Empirical Formula (Hill Notation): C54H90N6O18
Molecular Weight: 1111.32
EC Number: 217-896-6
MDL Number: MFCD00005114
Linear Formula: C54H90N6O18
Product Type: Chemical
antibiotic activity spectrum | mycobacteria |
assay | ≥99.0% (TLC) |
form | powder |
InChI | 1S/C54H90N6O18/c1-22(2)34 |
InChI key | FCFNRCROJUBPLU-RPUZOQEISA |
mode of action | cell membrane | interferes |
mp | 187-190 °C |
Quality Level | 200 |
SMILES string | CC(C)[C@@H]1NC(=O)[C@H](C |
storage temp. | 2-8°C |
Application: | Valinomycin has been used as an internal standard in the cytotoxicity assay for the detection of cereulide produced by emetic Bacillus cereus. It has also been used in the measurement of the electrogenicity of bile salt/H+ antiport in Escherichia coli. |
Biochem/physiol Actions: | K+-selective ionophoric cyclodepsipeptide; potassium ionophore which uncouples oxidative phosphorylation, induces apoptosis in murine thymocytes, inhibits NGF-induced neuronal differentiation and antagonizes ET-induced vasoconstriction. |
Biochem/physiol Actions: | Valinomycin affects the ion transport behavior of mitochondrial systems. |
General description: | Chemical structure: peptide |
General description: | Valinomycin is a neutral cyclic dodecadepsi-peptide antibiotic, that has a 36-member ring.Valinomycin consists of twelve stereogenic centers that are made of three repeating sequences of a tetramer of D-α-hydroxyisovalericacid |
Other Notes: | Review |
Symbol | GHS06 |
Signal word | Danger |
Hazard statements | H300 + H310 |
Precautionary statements | P262 - P280 - P301 + P310 + P330 - P302 + P352 + P310 |
Hazard Codes | T+ |
Risk Statements | 27/28 |
Safety Statements | 28-36/37-45 |
RIDADR | UN 2811 6.1 / PGI |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Purity | ≥99.0% (TLC) |
mp | 187-190 °C |
Storage Temp. | 2-8°C |
UNSPSC | 12352200 |